About Us - Suzhou Tianma Pharma Group Tianji Biopharma

ABOUT US

Founded in June 2000, Suzhou Tianji Biopharma is the flagship company of Suzhou Tianma Pharma Group and a national High-Tech Enterprise, home to a provincial-level Enterprise Technology Center in Jiangsu. With more than two decades focused on peptide pharmaceuticals, we bring R&D, manufacturing, sales, and technical services together under one roof. We operate across the full peptide and small-molecule value chain — peptide and small-molecule APIs, lyophilized powder injections, small-volume injectables, and topical formulations — complemented by custom peptide development and integrated CRO, CMO, and CDMO services, with complete in-house capabilities from synthesis, purification, and formulation development through regulatory filing and commercial-scale manufacturing. Our products span immunomodulation, women’s health, gastroenterology, pain management, oncology, and metabolic disease, with several having completed China’s generic drug consistency Evaluation. Our peptide APIs — including advanced classes such as GLP-1 and oral cyclic peptides — supply both domestic and international markets, with select products approved by overseas regulators. We are also steadily advancing a proprietary pipeline of improved (505(b)(2)-type) new drugs. Guided by strict GMP quality management and an ongoing commitment to innovation and quality, Tianji Biopharma remains dedicated to peptides — delivering reliable products and expert technical solutions to pharmaceutical partners worldwide.

NEW MANUFACTURING CAMPUS

Our new site at the Changshu New Materials Industrial Park is operational. 71,000 m² bringing peptide and small-molecule R&D, pilot, and commercial production onto one campus, built to international pharmaceutical standards.
Four API workshops (three peptide, one small-molecule), four GMP formulation workshops, and a 1,500 m² topical suite planned.
Peptide API — 1,500+ kg/year, hundreds of grams to tens of kilograms per batch Small-molecule API — ton-scale batches Injectables — 200M+ units/year (100M+ lyophilized, 100M+ small-volume) Topicals — hormonal and non-hormonal, next phase QC, warehousing, utilities, and R&D labs all on site — commercial supply for generic and innovative programs alike.

QUALIFICATIONS & HONORS

National High-Tech Enterprise
Jiangsu Provincial Enterprise Technology Center
Gazelle Enterprise
Key Biopharmaceutical Enterprise of Wuzhong District
2024 Outstanding Biopharmaceutical Product Brand
2024 Outstanding Biopharma Industry Partner

SOCIAL RESPONSIBILITY

Since its founding, Tianji has held to one mission — medicine made with compassion, serving the nation. We treat social responsibility as an active commitment: backing local education, sports and culture, support for people with disabilities and for military families, and stepping forward whenever emergencies, public health crises or major disasters strike.

When COVID-19 broke out in early 2020, our people gave up the Spring Festival holiday and returned to their posts to keep supply moving to the front line. The company donated LIDING® (Thymalfasin for Injection), an immunomodulator, to Hubei, Jiangsu, Zhejiang, Anhui, Yunnan, Jilin, Shaanxi, Fujian, Chongqing, Xinjiang and beyond — over RMB 5 million in total value.

In July 2016, under a paired-assistance program for Qinghai, Tianji donated medicines worth RMB 1.08 million to Hainan Tibetan Autonomous Prefecture through the Red Cross Society of Jiangsu Province, reinforcing healthcare on the plateau and living out the Red Cross spirit of humanity, fraternity and dedication.

Pharmaceuticals remain our core and public good our commitment. We will keep our founding mission, embed social responsibility into our long-term strategy, protect public health with quality medicines, and carry the responsibility a national pharmaceutical company owes to society.

STYLE

Tianji Biopharma: Setting a New Benchmark in Peptide Manufacturing, Powered by Intelligence and Standards

At Tianji, we hold ourselves to three benchmarks — intelligent manufacturing, international standards, and green, safe operations. They shape every inch of our production floor, and every measure of our respect for life.

Our modern manufacturing campus is fully aligned with EU/US cGMP requirements, underpinned by an end-to-end quality management system and a comprehensive EHS (Environment, Health & Safety) system. From peptide synthesis and purification through formulation filling and lyophilization, intelligent and automated equipment runs every critical step: process parameters captured automatically, monitored in real time and fully traceable — minimizing human intervention so every batch carries the same stable, consistent quality DNA. Cleanrooms strictly follow international cleanliness classifications, safeguarded by online particle monitoring and environmental systems on every dimension.

Quality is our baseline, and our belief. Incoming raw-material inspection, in-process intermediate testing and final product release run as a closed-loop system in strict GMP compliance — ready for every review by regulators at home and abroad. Our EHS system spans the full operational lifecycle, advancing production safety, environmental protection and occupational health together, so efficient manufacturing and green, safe operations move forward as one.

Tianji Biopharma — powered by intelligence, speaking the language of standards, committed to safety — is dedicated to making every peptide medicine a trusted answer for health.